Jennifer C. Price

Dr. Jennifer C. Price

Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
JPJennifer C. Price
Jennifer C. Price
ESEric C Seaberg
Eric C Seaberg
RLRachel Latanich
Rachel Latanich
MBMatthew J Budoff
Matthew J Budoff
LKLawrence A Kingsley
Lawrence A Kingsley
CTChloe L Thio
Chloe L Thio
AIDS Cohort Study (MACS). METHODS: In 719 MACS participants who consumed less than three alcoholic drinks daily, fatty liver was defined as a liver-to-spleen attenuation ratio <1 on noncontrast computed tomography (CT). We genotyped single nucleotide polymorphisms in the patatin-like phospholipase domain-containing 3 (PNPLA3) gene and in other genes previously associated with nonalcoholic fatty liver disease. Risk factors for fatty liver were determined using multivariable logistic regression. RESULTS: Among 254 HIV-uninfected men and 465 HIV-infected men, 56% were White with median age 53 years and median body mass index 25.8 kg/m2. The vast majority of HIV-infected men (92%) were on ART, and 87% of the HIV-infected men were treated with a nucleoside reverse transcriptase inhibitor for a median duration of 8.5 years. Overall, 15% of the cohort had fatty liver, which was more common in the HIV-uninfected compared with the HIV-infected men (19 vs. 13%,P=0.02). In multivariable analysis, HIV infection was associated with a lower prevalence of fatty liver (odds ratio (OR)=0.44,P=0.002), whereas a higher prevalence of fatty liver was seen in participants withPNPLA3(rs738409) non-CC genotype (OR=2.06,P=0.005), more abdominal visceral adipose tissue (OR=1.08 per 10 cm2,P<0.001), and homeostatic model assessment of insulin resistance (HOMA-IR) ≥4.9 (OR=2.50,P=0.001). Among HIV-infected men,PNPLA3(rs738409) non-CC genotype was associated with a higher prevalence of fatty liver (OR=3.30,P=0.001) and cumulative dideoxynucleoside exposure (OR=1.44 per 5 years,P=0.02). CONCLUSIONS: CT-defined fatty liver is common among men at risk for HIV infection and is associated with greater visceral adiposity, HOMA-IR, andPNPLA3(rs738409). Although treated HIV infection was associated with a lower prevalence of fatty liver, prolonged exposure to dideoxynucleoside analogs is associated with higher prevalence....

29 December 2023 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
SGSamer Gawrieh
Samer Gawrieh
EVEduardo Vilar‐Gomez
Eduardo Vilar‐Gomez
TWTinsay A. Woreta
Tinsay A. Woreta
JLJordan E. Lake
Jordan E. Lake
LWLaura A. Wilson
Laura A. Wilson
RLRohit Loomba
Rohit Loomba

28 January 2022 in Clinical Liver Disease
Verified
Journal Article
Open access
PDF file
JPJennifer C. Price
Jennifer C. Price
DSDinee C. Simpson
Dinee C. Simpson
Content available: Audio Recording


30 March 2015 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
JPJennifer C. Price
Jennifer C. Price
NTNorah A. Terrault
Norah A. Terrault

11 June 2019 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
AKAni Kardashian
Ani Kardashian
YMYifei Ma
Yifei Ma
MYMichael T Yin
Michael T Yin
RSRebecca Scherzer
Rebecca Scherzer
ONOlivia Nolan
Olivia Nolan
JPJennifer C. Price
Jennifer C. Price
Tryptophan catabolism, measured by the kynurenine:tryptophan (kyn/trp) ratio, is associated with gut microbiota alterations in people with HIV (PWH). We examined the association of the kyn/trp ratio with liver fibrosis in women with/without HIV infection. The plasma kyn/trp ratio was measured in 137 HIV-monoinfected, HIV/hepatitis C virus (HCV)–coinfected, and uninfected women in the Women’s Interagency HIV Study. Fibrosis was estimated using FIB-4 in all participants and vibration-controlled transient elastography liver stiffness measurement (LSM) in a subset (n = 83). We used multivariable linear regression to evaluate the associations of infection status and kyn/trp ratio with relative differences in fibrosis estimates. The median kyn/trp ratio (interquartile range) was 0.056 (0.045–0.066) in HIV/HCV-coinfected, 0.038 (0.032–0.046) in HIV-monoinfected, and 0.031 (0.025–0.034) in uninfected women (P < .001). After adjustment for sociodemographic, lifestyle, and metabolic factors, HIV monoinfection and HIV/HCV coinfection were associated with 37% (95% confidence interval [CI], 9% to 73%) and 164% (95% CI, 100% to 250%) greater FIB-4, respectively. When kyn/trp ratio was included, higher kyn/trp ratio was associated with greater FIB-4 (27% per kyn/trp doubling; 95% CI, 5% to 53%), and the associations of HIV monoinfection (29% per kyn/trp doubling; 95% CI, 2% to 63%) and HIV/HCV coinfection (123% per kyn/trp doubling; 95% CI, 63% to 203%) with greater FIB-4 were attenuated. Among those with LSM, higher kyn/trp ratio was associated with greater LSM (43% per kyn/trp doubling; 95% CI, 15% to 79%) in multivariable analysis. The kyn/trp ratio is elevated in PWH and is associated with greater liver fibrosis. Tryptophan catabolism may modify the relationships between HIV, HCV, and fibrosis.